10 results
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... - performed on dyspneic ... #BLUE #protocol ... #Algorithm #Dyspnea ... #Pulmonary #Ultrasound
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... - performed on dyspneic ... #protocol #Algorithm ... #Dyspnea #CriticalCare ... #POCUS #Lung #Pulmonary
The BLUE-protocol decision tree - performed on dyspneic patients who will be admitted to the ICU

The
The BLUE-protocol ... - performed on dyspneic ... the ICU The BLUE-protocol ... , a half B-profile ... www.grepmed.com/images/11924/dyspnea-criticalcare-pulmonary-algorithm-pocus
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... pain, hemoptysis, dyspnea ... #Abscess #pulmonary ... #differential #causes ... #management #treatment
Hepatopulmonary Syndrome - Diagnosis and Management Summary
A defect in arterial oxygenation due to a gas exchange
absence of intrinsic lung ... disease Caused ... Presentation: • Dyspnea ... • Platypnea - Dyspnea ... on radioactive lung
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
Unknown • 6-7 cases ... History: cough, dyspnea ... Organizing Pneumonia Treatment ... Pneumonia #COP #BOOP #pulmonary ... ILD #diagnosis #management
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
• Amiodarone half ... starting amiodarone treatment ... Dyspnea 3. ... macrophages Treatment ... #diagnosis #management
Management of patients with known or suspected malignant pleural effusion (MPE) - An Official ATS/STS/STR Clinical
Management of patients ... goals of assessing lung ... and relief of dyspnea ... #Algorithm #Effusion ... #Pleural #Pulmonary
Essential Thrombocythemia (ET)
ET is a chronic myeloproliferative neoplasm. Most cases are related to mutations that affect
Most cases are related ... JAK2, CALR-calreticulin ... • Treatment algorithms ... #diagnosis #management ... #hematology
Anti-NXP-2 Dermatomyositis

What?
DM with generalized subcutaneous edema
Pts have more myalgias, more severe weakness, and an increased prevalence
Periorbital heliotrope (blue-purple ... Muscle atrophy may cause ... positive patients Treatment ... Dermatomyositis #diagnosis #management ... #rheumatology #dermatology